Dose model for a beta-emitting stent in a realistic artery consisting of soft tissue and plaque

Medical Physics

Volumn 26, Issue 11, 1999, Pages 2451-2460

  Janicki, Christian ^a   Duggan, Dennis M ^b   Gonzalez, Albin ^b   Coffey II, Charles W ^b   Rahdert, David A ^c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Isostent Inc   (United States)

Author keywords

Beta dosimetry; Intravascular brachytherapy; Radioactive stent

Indexed keywords

DOSIMETRY; PHANTOMS; TISSUE;

HETEROGENEOUS MEDIUM; INTRAVASCULAR BRACHYTHERAPY; POLYTETRAFLUOROETHYLENE (PTFE); RADIOACTIVE STENT; RADIOCHROMIC FILM; RADIOCHROMIC FILM DOSIMETRY; SCALING PROPERTIES; WATER EQUIVALENT PHANTOMS;

STENTS;

PHOSPHORUS 32; POLITEF;

ARTICLE; BETA RADIATION; BRACHYTHERAPY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DOSIMETRY; PHANTOM; PRIORITY JOURNAL; RADIATION DOSE; RESTENOSIS; SOFT TISSUE;

EID: 0032742628     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.598813     Document Type: Article

References (37)

1. R. L. Wuderman, D. E. Hilleman, and A. N. Mooss, "Restenosis, the Achiles' heel of coronary angioplasty," Pharmacotherapy 18, 1024-1040 (1998).
2. P. W. Serruys et al., Benestent Study Group, "A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease," N. Engl. J. Med. 331, 489-495 (1994).
3. G. R. Dussaillant, G. S. Mintz, A. D. Pichard, K. M. Kent, L. F. Satler, J. J. Popma, S. C. Wong, and M. B. Leon, "Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis," J. Am. Coll. Cardiol. 26, 720-724 (1995).
4. P. S. Terstein, "Prevention of vascular restenosis with radiation," Tex. Heart Inst. J. 25, 30-33 (1998).
5. R. Waksman, "Endovascular brachytherapy: overcoming practical obstacles," Am. J. Cardiol. 81, 21E-26E (1998).
6. D. O. Williams, "Radiation vascular therapy: a novel approach to preventing restenosis," Am. J. Cardiol. 81, 18E-20E (1998).
7. G. S. Mintz, R. Hoffmann, R. Mehran, A. D. Picard, K. M. Kent, L. F. Satler, J. J. Popma, and M. B. Leon, "In-stent restenosis: the Washington Hospital Center experience," Am. J. Cardiol. 81, 7E-13E (1998).
8. G. Noel, L. Feuvret, J. Bourhis, F. Pousset, A. Gerbaulet, Y. Popowsky, and J. J. Mazeron, "Role of intravascular brachytherapy in the prevention of vascular restenosis after angioplasty," Cancer Radiother. 2, 325-337 (1998).
9. A. J. Carter and T. A. Fischell, "Current status of radioactive stents for the prevention of in-stent restenosis," Int. J. Radial. Oncol. Biol. Phys. 41, 127-133 (1998).
10. T. A. Fischell and C. Hehrlein, "The radioisotope stent for the prevention of restenosis," Herz 23, 373-379 (1998).
11. C. Hehrlein and T. Fischell, "History of the radioisotope stent," Vascular Radiotherapy Monitor 1, 66-69 (1999).
12. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43," Med. Phys. 22, 209-234 (1995).
13. C. Janicki, D. M. Duggan, C. Coffey, D. R. Fischell, and T. A. Fischell, "Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent," Med. Phys. 24, 437-445 (1997).
14. 32P coated stent," Med. Phys. 22, 313-320 (1995).
15. W. V. Prestwich, J. Nunes, and C. S. Kwok, "Beta dose point kernels for radionuclides of potential use in radioimmunotherapy," J. Nucl. Med. 30, 1036-1046 (1989).
16. C. Janicki, D. R. Fischell, K. Krumme, and M. Perry, "Application of the DPK model to predict the dose field around a P-32 advanced stent design," Med. Phys. 24, 994 (1997).
17. W. G. Cross, "Variation of beta dose attenuation in different media," Phys. Med. Biol. 13, 611-618 (1968).
18. M. J. Berger, Distribution of absorbed dose around a point source of electrons and beta particles in water and other media, MIRD Pamphlet No. 7, Nucl. Medicine 12, Supplement No. 5, 5-23, 1971.
19. ICRU Report 56, Dosimetry of External Beta Rays for Radiation Protection (International Commission on Radiation Units and Measurements, Bethesda, MD, 1997).
20. J. S. Durham, Varskin Mod 2 and Sadde Mod 2: Computer codes for assessing skin dose from skin contamination, NUREG/CR-5873, U.S. Nuclear Regulatory Commission, Washington, DC 1999.
21. D. M. Duggan, C. W. Coffey, and S. Levit, "Dose distribution for a 32P-impregnated coronary stent: comparison of theoretical calculations and measurements with radiochromic film," Int. J. Radiat. Oncol. Biol. Phys. 40, 713-720 (1998).
22. C. W. Coffey and D. M. Duggan, Dosimetric considerations and dose measurement analysis of phosphorus 32 beta-emitting stents, in Vascular Brachytherapy, 2nd ed., edited by R. Waksman (Futura, Armonk, NY, 1999), pp. 313-332.
23. A. N. Li, N. L. Eigler, F. Litvack and J. S. Whiting, "Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy," Med. Phys. 25, 20-28 (1998).
24. W. L. McLaughlin et al., "Sensitometry of the response of a new radiochromic film dosimeter to gamma radiation and electron beams," Nucl. Instrum. Methods Phys. Res. A 302, 165-176 (1991).
25. J. A. Sayeg and C. W. Coffey, "The energy response of "GafChromic" radiation detectors," Med. Phys. 17, 521 (1991).
26. C. G. Scares and W. L. McLaughlin, "Measurement of radial dose distributions around small beta-particle emitters using high-resolution radiochromic foil dosimetry," Radiat. Prot. Dosim. 47, 367-372 (1993).
27. A. S. Meigooni, M. F. Sanders, G. S. Ibbott, and S. R. Szeglin, "Dosimetric characteristics of an improved radiochromic film," Med. Phys. 23, 1883-1888 (1996).
28. Y. Zhu, A. S. Kirov, V. Mishra, A. S. Meigooni, and J. F. Williamson, "Quantitative evalualion of radiochromic film response for two-dimensional dosimetry," Med. Phys. 24, 223-231 (1997).
29. A. Niroomand-Rad, C. R. Blackwell, B. M. Coursey, K. P. Gall, J. M. Galvin, W. L. McLaughlin, A. S. Meigooni, R. Nath, J. E. Rodgers, and C. G. Soares, "Radiochromic film dosimetry: Recommendations of AAPM Radiation Therapy Task Group 55," Med. Phys. 25, 2093-2115 (1998).
30. Task Group 21, Radiation Therapy Committee AAPM, "A protocol for calibration of high energy photon and eleclron beams," Med. Phys. 10, 741 (1983).
31. F. H. Attix, "A simple derivation of Ngas, a correction in Awall, and other comments on the AAPM Task Group 21 protocol," Med. Phys. 11, 725-728 (1984).
32. F. H. Attix, Introduction to Radiological Physics and Radiation Dosimetry (Wiley-Interscience, New York, 1986).
33. R. J. Schulz, P. R. Almond, G. Kutcher, R. Lovinger, R. Nath, D. W. Rogers, N. Suntharalingam, K. A. Wright, and F. M. Kahn, "Clarification of the AAPM Task Group 21 protocol," Med. Phys. 13, 755-759 (1986).
34. D. M. Duggan and C. W. Coffey, "Better narrow beam profiles by exposing a stack of radiochromic films and averaging the readings," Med. Phys. (in press).
35. K. S. Arun, T. S. Huang, and S. D. Blostein, "Least-squares fitting of two 3-D point sets," IEEE Trans. Pattern. Anal. Mach. Intell. PAMI-9, 698-700 (1997).
36. 32P dose backscatter factors al and near soft-tissue boundaries," Med. Phys. 20, 223-231 (1993).
37. S. M. Marcu and W. V. Prestwich, "Application of the scaling factor method to estimation of beta dose distributions for dissimilar media separated by a planar interface," Med. Phys. 25, 1478-1486 (1998).